Login / Signup

Response to Letter to the Editor from Chatelain et al.: Weekly Somapacitan is Effective and Well Tolerated in Children with GH Deficiency: The Randomized Phase 3 REAL4 Trial.

Bradley S MillerJoanne C BlairMichael Højby RasmussenAristides ManiatisRasmus Juul KildemoesJun MoriMichel PolakRikke Beck BangVolker BöttcherStefano StagiReiko Horikawa
Published in: The Journal of clinical endocrinology and metabolism (2023)
Keyphrases
  • phase iii
  • phase ii
  • open label
  • double blind
  • clinical trial
  • placebo controlled
  • study protocol
  • young adults
  • growth hormone
  • replacement therapy
  • randomized controlled trial